Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/25778
Title: | The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective |
Authors: | Ansari, S Hays, JP Kemp, A Okechukwu, R Murugaiyan, J Ekwanzala, MD Ruiz Alvarez, MJ Paul-Satyaseela, M Iwu, CD Balleste-Delpierre, C Septimus, E Mugisha, L Fadare, J Chaudhuri, S Chibabhai, V Wadanamby, JMRWW Daoud, Z Xiao, Y Parkunan, T Khalaf, Y M'Ikanatha, NM Van Dongen, MBM Global AMR Insights Ambassador Network Barkema, HW Strathdee, S Benyeogor, E Ighodalo, UL Prasad, KP Carlos, M Gu, Y Essack, S De Silva, D Vellinga, A Mommtaz Ghannam, W Tsoho, NA Sakeena, MHF Ilenwabor, R Shetty, D Ayebare, A Traore, ZI Henry, O Kiran, A Ilanwabor, R Toro, LF Smail, A Amulele, A Founou, LL Sawant, PS Buregyeya, E Castro-Sánchez, E Moreno-Morales, J Izadjoo, M Gori, A Goff, D Blocker, A Forte, G Tahir, MF Diggle, M Chakraborty, D Asamoah, AE Aberi, H |
Keywords: | antibiotics;coronavirus;critical illness;drug resistance;microbial;vaccination;world health;infections;diagnosis;pathogenic organism;antimicrobials;biocides;antimicrobial stewardships;ars-cov-2;covid-19;coronavirus pandemic |
Issue Date: | 8-Apr-2021 |
Publisher: | Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy |
Citation: | Ansari, S. et al on behalf of Global AMR Insights Ambassador Network (2021) 'The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective', JAC-Antimicrobial Resistance, 3 (2), dlab038, pp. 1 - 12. doi: 10.1093/jacamr/dlab038. |
Abstract: | Copyright © The Author(s) 2021. The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic’s potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic’s effect on global AMR. |
URI: | https://bura.brunel.ac.uk/handle/2438/25778 |
DOI: | https://doi.org/10.1093/jacamr/dlab038 |
Other Identifiers: | ORCID iDs: Shamshul Ansari https://orcid.org/0000-0003-1846-1377; Maneesh Paul-Satyaseela https://orcid.org/0000-0002-6702-4942; Joseph Fadare https://orcid.org/0000-0002-5641-1402; Yara Khalaf https://orcid.org/0000-0002-8013-7140; Nkuchia M M’Ikanatha
https://orcid.org/0000-0002-5631-184X; Enrique Castro-Sánchez https://orcid.org/0000-0002-3351-9496. dlab038 |
Appears in Collections: | Dept of Arts and Humanities Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | Copyright © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com | 759.68 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License